Overview


The economy of the People’s Republic of China (PRC) has undergone a rapid transformation in a relatively short time—as have its antitrust and competition laws and regulations. Since the country’s Anti-Monopoly Law (AML) was implemented in 2008, the Supreme Court of China (SPC) has redefined many of its judicial procedures, while the Ministry of Commerce (MOFCOM), the National Development and Reform Commission (NDRC) and the State Administration of Industry and Commerce (SAIC), among other bodies, have begun to aggressively enforce the newly enacted law.

Show More

Results


  • A global pharmaceutical company in the NDRC’s anti-monopoly investigation into several of the client’s pharmaceuticals and medical device divisions
  • A multinational producer of nutritional products in an AML investigation by China’s enforcement agencies and in leniency negotiations
  • A global health care company in its filings with PRC antitrust authorities in relation to its merger with another multinational in one of the largest mergers in China’s history

Show More

People


To meet these multi-front challenges, clients need legal counsel with experience, international reach and familiarity with all major national and international regulatory regimes and dispute-resolution forums. With a talented team and depth across our offices, McDermott provides effective, coordinated counsel on US antitrust law, EC competition law, China’s Anti-Monopoly Law and other competition laws worldwide.

Key Contacts


Raymond A. Jacobsen, Jr.

View Profile